ConductScience.org, home

Paper36933125

Yellow Subthreshold Micropulse Laser in Retinal Diseases: An In-Depth Analysis and Review of the Literature.

Iovino C and 7 others. Ophthalmol Ther, 2023. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. Yellow Subthreshold Micropulse Laser in Retinal Diseases: An In-Depth Analysis and Review of the Literature. Papers, record 36933125. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36933125

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Yellow Subthreshold Micropulse Laser in Retinal Diseases: An In-Depth Analysis and Review of the Literature.
PubMed
Journal
Ophthalmol Ther
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
5.41
iCite
Revised in PubMed
2023-05-09
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Iovino CClaudio
2Iodice CMClemente Maria
3Pisani DDanila
4Rosolia AAndrea
5Testa FFrancesco
6Giannaccare GGiuseppe
7Chhablani JJay
8Simonelli FFrancesca

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References133

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127841848NONDAMAGING RETINAL LASER THERAPY FOR TREATMENT OF CENTRAL SEROUS CHORIORETINOPATHY: What is the Evidence?Retina2017https://conductscience.org/library/papers/27841848PubMed
225613846Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome.Eye (Lond)2015https://conductscience.org/library/papers/25613846PubMed
325650711LASER RESENSITIZATION OF MEDICALLY UNRESPONSIVE NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Efficacy and Implications.Retina2015https://conductscience.org/library/papers/25650711PubMed
417021318Ranibizumab for neovascular age-related macular degeneration.N Engl J Med2006https://conductscience.org/library/papers/17021318PubMed
529439089
Yellow (577 nm) micropulse laser versus half-dose verteporfin photodynamic therapy in eyes with chronic central serous chorioretinopathy: results of the Pan-American Collaborative Retina Study (PACORES) Group.
Br J Ophthalmol2018https://conductscience.org/library/papers/29439089PubMed
634110452Subthreshold laser therapy with a standardized macular treatment pattern in chronic central serous chorioretinopathy.Graefes Arch Clin Exp Ophthalmol2021https://conductscience.org/library/papers/34110452PubMed
716563382Focus on molecules: glial fibrillary acidic protein (GFAP).Exp Eye Res2007https://conductscience.org/library/papers/16563382PubMed
827159441Nondamaging Retinal Laser Therapy: Rationale and Applications to the Macula.Invest Ophthalmol Vis Sci2016https://conductscience.org/library/papers/27159441PubMed
910758221Micropulse laser in the treatment of diabetic macular edema.Semin Ophthalmol1999https://conductscience.org/library/papers/10758221PubMed
102866759Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.Arch Ophthalmol1985https://conductscience.org/library/papers/2866759PubMed
1121087969Non-damaging retinal phototherapy: dynamic range of heat shock protein expression.Invest Ophthalmol Vis Sci2011https://conductscience.org/library/papers/21087969PubMed
1229651345Subthreshold Photocoagulation Using Endpoint Management in the PASCAL® System for Diffuse Diabetic Macular Edema.J Ophthalmol2018https://conductscience.org/library/papers/29651345PubMed
1327597894Low-Fluence Photodynamic Therapy versus Subthreshold Micropulse Yellow Wavelength Laser in the Treatment of Chronic Central Serous Chorioretinopathy.J Ophthalmol2016https://conductscience.org/library/papers/27597894PubMed
1433062394Subthreshold Micropulse Laser in Diabetic Macular Edema: 1-Year Improvement in OCT/OCT-Angiography Biomarkers.Transl Vis Sci Technol2020https://conductscience.org/library/papers/33062394PubMed
1524171809Branch retinal vein occlusion: treatment modalities: an update of the literature.Semin Ophthalmol2014https://conductscience.org/library/papers/24171809PubMed
1610360304The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery.Trans Am Ophthalmol Soc1998https://conductscience.org/library/papers/10360304PubMed
1731296907Sub-threshold micropulse laser treatment reduces inflammatory biomarkers in aqueous humour of diabetic patients with macular edema.Sci Rep2019https://conductscience.org/library/papers/31296907PubMed
1830457660Single Retinal Layer Changes After Subthreshold Micropulse Yellow Laser in Diabetic Macular Edema.Ophthalmic Surg Lasers Imaging Retina2018https://conductscience.org/library/papers/30457660PubMed
1932953579Efficacy of the subthreshold micropulse yellow wavelength laser photostimulation in the treatment of chronic central serous chorioretinopathy.Int J Ophthalmol2020https://conductscience.org/library/papers/32953579PubMed
2016606869Idiopathic macular telangiectasia.Arch Ophthalmol2006https://conductscience.org/library/papers/16606869PubMed

See all 133 referencesDownload CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
42934554Quantitative choroidal evaluation after subthreshold micropulse laser in chronic central serous chorioretinopathy using ultrawide-field SS-OCTA.BMC Ophthalmol2026https://conductscience.org/library/papers/42934554PubMed
42769567Research advances in the translational application of anti-VEGF combined with subthreshold micropulse laser therapy for refractory diabetic macular edema.Am J Transl Res2026https://conductscience.org/library/papers/42769567PubMed
42371171Subthreshold micropulse laser for subretinal fluid after vitrectomy in myopic traction maculopathy: a pilot randomized controlled trial.Lasers Med Sci2026https://conductscience.org/library/papers/42371171PubMed
41907281Efficacy and safety of subthreshold micropulse laser for chronic central serous chorioretinopathy: a systematic review and meta-analysis.Front Med (Lausanne)2026https://conductscience.org/library/papers/41907281PubMed
40976848Clinical efficacy of conbercept combined with micropulse laser in patients with polypoidal choroidal vasculopathy.Lasers Med Sci2025https://conductscience.org/library/papers/40976848PubMed
40788772A case of macular damage following micropulse laser treatment for central serous chorioretinopathy.J Int Med Res2025https://conductscience.org/library/papers/40788772PubMed
40232363[Retinal survival of the outer retinal layers after subthreshold micropulse laser therapy for traumatic macular hole].Ophthalmologie2025https://conductscience.org/library/papers/40232363PubMed
39941624Subthreshold Laser Titration Database in a Population with Central Serous Chorioretinopathy and Dome-Shaped Macula.J Clin Med2025https://conductscience.org/library/papers/39941624PubMed
39733268PHOTOBIOMODULATION THERAPY FOR SEROUS PIGMENT EPITHELIUM DETACHMENT IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.Retin Cases Brief Rep2025https://conductscience.org/library/papers/39733268PubMed
39497141Fluorescein angiography patterns and subretinal hyperreflective material predict subthreshold micropulse laser response in chronic central serous chorioretinopathy.BMC Ophthalmol2024https://conductscience.org/library/papers/39497141PubMed
39407788Settings and Clinical Applications of Subthreshold Micropulse Laser Therapy: A Review.J Clin Med2024https://conductscience.org/library/papers/39407788PubMed
39274219Intravitreal Dexamethasone Implant Switch after Anti-VEGF Treatment in Patients Affected by Retinal Vein Occlusion: A Review of the Literature.J Clin Med2024https://conductscience.org/library/papers/39274219PubMed
38929708Switching to an Intravitreal Dexamethasone Implant after Intravitreal Anti-VEGF Therapy for Diabetic Macular Edema: A Review.Life (Basel)2024https://conductscience.org/library/papers/38929708PubMed
38765459A Two-Decade Bibliometric Analysis of Laser in Ophthalmology: From Past to Present.Clin Ophthalmol2024https://conductscience.org/library/papers/38765459PubMed
38274400Navigated yellow subthreshold micropulse laser for refractory cystoid macular edema following rhegmatogenous retinal detachment surgery.Am J Ophthalmol Case Rep2024https://conductscience.org/library/papers/38274400PubMed
38038727Editorial to: The effect of nondamaging subthreshold laser therapy in patients with chronic central serous chorioretinopathy.Graefes Arch Clin Exp Ophthalmol2024https://conductscience.org/library/papers/38038727PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GFAP2670PubTator's text mininghttps://conductscience.org/library/genes/2670NCBI Gene
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36933125

GET https://conductscience.org/api/papers/v1/36933125/references?page=2